In this article, we will be taking a look at the 5 most valuable medical device companies in the US. If you wish to learn about more companies, head straight to the 25 Most Valuable Medical Device Companies in the US.
5. Intuitive Surgical, Inc. (NASDAQ:ISRG)
Market Capitalization: $133.401B
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the most valuable medical device companies in the US, known for its da Vinci Surgical System, enabling precise, minimally invasive procedures. Its technology advances minimally invasive surgery, reducing patient trauma and faster recovery. Intuitive Surgical, Inc. (NASDAQ:ISRG)’s future growth will continue through innovation, expansion into new specialties, and global system adoption.
4. Danaher Corporation (NYSE:DHR)
Market Capitalization: $184.8B
Danaher Corporation (NYSE:DHR), a leading US medical device company, reported a remarkable revenue increase to $22.3 billion in 2021, with significant growth in gross profit and net earnings. Strategic acquisitions, like General Electric Co.’s biopharmaceutical business, increased sales by 18%. The acquisition of Cytiva positions Danaher Corporation (NYSE:DHR) as a critical player in the global biopharmaceutical arena, focusing on bioprocessing technologies, with a projected growth of 17% annually over the next five years.
3. Abbott Laboratories (NYSE:ABT)
Market Capitalization: $197.928B
Abbott Laboratories (NYSE:ABT), a top medical device company in the company, operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Medical Devices segment offers a variety of products, including electrophysiology, heart failure, vascular, structural heart, diabetes care, and neuromodulation devices. Abbott Laboratories (NYSE:ABT) is expected to continue innovating in the medical device and healthcare industry, offering various products addressing various healthcare needs, from diagnostics to chronic disease management.
2. Thermo Fisher Scientific Inc. (NYSE:TMO)
Market Capitalization: $211.67B
Thermo Fisher Scientific Inc. (NYSE:TMO), a leading medical device company in the US, aims to enhance global health, cleanliness, and safety. Guided by core values like integrity and innovation, it operates across four segments: Life Sciences, Analytical Instruments, Specialty Diagnostics, and Laboratory Products. Serving over 400,000 customers worldwide, and employing 51,000 people in 50 countries, Thermo Fisher Scientific Inc. (NYSE:TMO) emphasizes cost efficiency through automation. Prospects are bright due to its strong market position, innovation focus, and CSR initiatives, contributing significantly to research, diagnostics, and treatment development, thus cementing its pivotal role in the medical device industry.
1. Johnson & Johnson (NYSE:JNJ)
Market Capitalization: $376.86B
Johnson & Johnson (NYSE:JNJ) is the biggest medical device company in the US with pharmaceuticals, medical devices, and consumer products divisions. Its Medical Devices Segment offers orthopedics, surgery, interventional solutions, and vision products. J&J reported sales of $21.35 billion in Q3 2023. Johnson & Johnson (NYSE:JNJ)’s robust R&D budget covers various areas, including neuroscience, oncology, and vaccines. J&J’s future trends are driven by solid pharmaceutical and medical device sales, backed by an R&D focus and a diverse product portfolio.
Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily enewsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also take a peek at the 25 Most Valuable Tech Companies Outside The US and the Top 20 Most Valuable Blockchain Companies in 2024.
